Le Lézard
Classified in: Health
Subject: PER

David Morrison M.D., Joins The Oncology Institute of Hope and Innovation


CERRITOS, Calif., Jan. 24, 2020 /PRNewswire-PRWeb/ -- Dr. Morrison received his medical degree from Baylor College of Medicine in Houston, Texas where he graduated cum laude. He has a Ph.D. in Cell Biology from Baylor College of Medicine where he graduated summa cum laude. He completed Hematology/Medical Oncology training and fellowship from Tulane University in New Orleans, Louisiana, an Internal Medicine Residency Training from Louisiana State University Medical Center in Lafayette, Louisiana and an Internal Medicine Internship and Residency Training from the University of Texas Southwestern Medical Center Affiliated Hospitals in Dallas, Texas.

Dr. Morrison remains active with clinical studies, research projects, and post-graduate training. He strives to stay up to date with current cutting edge treatment. He believes in having an open line of communication with his patients and their loved ones.

Professional Membership
Association of Physicians and Surgeons
Association for Cancer Research
Society of Oncology
Society of Hematology
Society of Internal Medicine
College of Physicians
Medical Association

About The Oncology Institute
Founded in 2007, The Oncology Institute of Hope and Innovation is dedicated to excelling in cancer prevention, diagnosis, and education. As the largest private practice cancer center in California, The Oncology Institute continues to provide extensive services including state-of-the-art infusion centers, chemotherapy educational sessions, in-house support groups, dietary and nutritional counseling, in-house pharmacy, financial counseling, clinical trials, comprehensive lab testing, and end of life counseling. They also offer support programs to help patients and families cope with the challenges brought on by cancer. Today, the Oncology Institute has served over 100,000 patients throughout 32 locations in Southern California, 5 in Arizona and 3 in Nevada.

 

SOURCE The Oncology Institute of Hope and Innovation


These press releases may also interest you

at 06:21
Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for sustainability and humanitarianism, today announced the deployment of AI-powered mammography services across Costa Rica to support the...

at 06:18
Surrey FA and Chelsea FC Foundation are proud to announce their collaborative effort once again to offer empowering coaching sessions to female refugees in the local community. These sessions will provide an opportunity for women to engage with...

at 06:05
BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....

at 06:05
Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss...

at 06:05
SprintRay, the leader in dental 3D printing, unveiled the Company's most significant innovation to-date to over 250 dental professionals at 3DNext, their summit in Miami. The Midas Digital Press 3D Printer is poised to not only transform dental...

at 06:00
Panacea Healthcare Solutions,...



News published on and distributed by: